2023
DOI: 10.1016/j.neubiorev.2023.105107
|View full text |Cite
|
Sign up to set email alerts
|

Use of experimental medicine approaches for the development of novel psychiatric treatments based on orexin receptor modulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 290 publications
0
2
0
Order By: Relevance
“…Similarly, risky decision-making is not a usual measure of therapeutic success. Nonetheless, it has been argued that approaches aiming to investigate efficacy of interventions consider the use of such experimental medicine measures ( Beckenstrom et al, 2023 ). Considering these factors, the positive results of the study may be limited in determining the success of the intervention, in turn potentially limiting the transferability of findings to other contexts.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, risky decision-making is not a usual measure of therapeutic success. Nonetheless, it has been argued that approaches aiming to investigate efficacy of interventions consider the use of such experimental medicine measures ( Beckenstrom et al, 2023 ). Considering these factors, the positive results of the study may be limited in determining the success of the intervention, in turn potentially limiting the transferability of findings to other contexts.…”
Section: Discussionmentioning
confidence: 99%
“…Other neuropeptides, including orexin, oxytocin, and melanocortin 4 (MC4) receptors, have also been linked to nicotine addiction and/or stress-induced nicotine relapse. Orexin, a neuropeptide that has been linked to emotion, sleep, and stress response [132][133][134][135], may be a potential therapeutic target for controlling nicotine use [136,137]. Intra-cerebroventricular injection of orexin-1 could reinstate extinguished nicotine-seeking behavior, suggesting that orexin-1 might be involved in nicotine relapse [56].…”
Section: Other Peptide Systemsmentioning
confidence: 99%
“…Orexins are excitatory neuropeptides, produced by a small number of neurons in the hypothalamus, that project to (and receive input from) many areas of the brain including well‐characterized centers of natural (food) and synthetic (drugs) reward signal processing/integration. Not surprisingly, the orexin system has emerged as an important new drug target for neuropsychiatric conditions due to its role in diverse brain functions (Beckenstrom et al, 2023). Preclinical studies suggest that orexin neuropeptides regulate intake of highly palatable food and compulsive behavior, stress processing, and the motivation for obtaining rewards mainly through activation of orexin 1 receptor (OX1R), as well as sleep and wakefulness mainly through orexin 2 receptor (OX2R) (Merlo Pich & Melotto, 2014; Tsujino & Sakurai, 2013).…”
Section: Introductionmentioning
confidence: 99%